VERAXA Biotech Raises $27.5M
VERAXA Biotech secures financing and plans to go public via SPAC, aiming to expand its biotech operations. The deal values the company and provides growth capital.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.